ID: ALA4593964

Max Phase: Preclinical

Molecular Formula: C38H60N4O7

Molecular Weight: 684.92

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CO/C1=C\CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@H](N(C)C)[C@@H](C)O2)[C@H](C)C[C@@H]2C[C@H](OCc3cn(CC4CCCCC4)nn3)O[C@@H]12

Standard InChI:  InChI=1S/C38H60N4O7/c1-26-21-30-22-37(45-25-31-24-42(40-39-31)23-29-14-10-8-11-15-29)49-38(30)34(44-6)18-19-35(43)46-27(2)13-9-7-12-16-33(26)48-36-20-17-32(41(4)5)28(3)47-36/h7,9,12,16,18,24,26-30,32-33,36-38H,8,10-11,13-15,17,19-23,25H2,1-6H3/b9-7+,16-12+,34-18-/t26-,27-,28-,30-,32+,33+,36+,37-,38-/m1/s1

Standard InChI Key:  BZBWPTZBWHUWGK-IDLQJWNSSA-N

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

KB 17409 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

NHDF 1164 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Bacillus spizizenii 1898 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus epidermidis 22802 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Micrococcus luteus 7463 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Streptococcus pneumoniae 31063 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 684.92Molecular Weight (Monoisotopic): 684.4462AlogP: 6.34#Rotatable Bonds: 9
Polar Surface Area: 106.40Molecular Species: BASEHBA: 11HBD: 0
#RO5 Violations: 3HBA (Lipinski): 11HBD (Lipinski): 0#RO5 Violations (Lipinski): 3
CX Acidic pKa: CX Basic pKa: 9.26CX LogP: 5.86CX LogD: 4.00
Aromatic Rings: 1Heavy Atoms: 49QED Weighted: 0.27Np Likeness Score: 0.83

References

1. Klich K, Pyta K, Kubicka MM, Ruszkowski P, Celewicz L, Gajecka M, Przybylski P..  (2016)  Synthesis, Antibacterial, and Anticancer Evaluation of Novel Spiramycin-Like Conjugates Containing C(5) Triazole Arm.,  59  (17): [PMID:27501415] [10.1021/acs.jmedchem.6b00764]

Source